Mixed connective tissue disease with multiple organ damage: successful treatment with plasmapheresis.

Abstract

A 24-year-old-woman with mixed connective tissue disease (MCTD) developed multiple organ failure, disseminated intravascular coagulation (DIC), metabolic acidosis, and respiratory and renal failure resulting from visceral vasospasm, so-called visceral Raynaud's phenomenon. After plasmapheresis, the condition of multiple organ failure was markedly improved. The successful treatment with plasmapheresis was dependent upon the removal of immune complexes in serum and improvement of visceral circulation. Thus plasma exchange is recommended as a possible a treatment for multiple organ damage in MCTD.

• Authors: M Seguchi, Y Soejima, A Tateishi, H Iida, M Yamamoto, K Nakashima, F Murakami, S Ohashi, S Yamashita, T Maekawa, A Murashige, S Umemoto, M Matsuzaki, Y Fukumoto
• Journal: Internal medicine (Tokyo, Japan) (Intern Med) Vol. 39 Issue 12 Pg. 1119-22 (Dec 2000) ISSN: 0918-2918 [Print] Japan
• PMID: 11197805 (Publication Type: Case Reports, Journal Article)

Chemical References

• Autoantigens
• Immunosuppressive Agents
• Ribonucleoprotein, U1 Small Nuclear
• Cyclosporine
• Methylprednisolone

Topics

• Acidosis (etiology)
• Adult
• Autoantigens (immunology)
• Autoimmune Diseases (complications, pathology, therapy)
• Bronchitis (etiology)
• Calcinosis (etiology)
• Combined Modality Therapy
• Cyclosporine (therapeutic use)
• Disseminated Intravascular Coagulation (etiology)
• Female
• Hemorrhage (etiology)
• Humans
• Immunosuppressive Agents (therapeutic use)
• Ischemia (etiology)
• Methylprednisolone (therapeutic use)
• Mixed Connective Tissue Disease (complications, drug therapy, pathology, therapy)
• Multiple Organ Failure (etiology, therapy)
• Plasmapheresis
• Ribonucleoprotein, U1 Small Nuclear (immunology)
• Vasoconstriction
• Viscera (blood supply)